Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
King's College London
Headquarters: London, United Kingdom
Website: http://kcl.ac.uk/
Year Founded: 1829
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Feb 10, 2023
Deals
Feb. 9 Quick Takes: AbbVie’s Gonzalez says next deal could be ‘much larger’ than $2B
Plus: Full approval for Jemperli and updates from AZ, Regeneron, Prokarium and more
BioCentury | Feb 2, 2023
Emerging Company Profile
PrecisionLife: learning from genetic interactions by cutting noise
U.K. company untangling genomic interactions to find targets in complex diseases
BioCentury | Sep 28, 2022
Emerging Company Profile
Pheon: advancing ADCs with first-in-class mAb, payload platform
Start-up banks $68M series A from Brandon, Forbion and Atlas; seeks to improve on a prior attempt to design new ADC payloads
BioCentury | Jun 20, 2022
Deals
U.K. partners to accelerate gene therapy development for dementia
CGT Catapult, UK DRI to work with academic centers to identify assets
BioCentury | Jun 4, 2022
Emerging Company Profile
Heqet: regenerating heart muscle cells via the Hippo pathway
King’s College spinout is inducing cardiomyocyte regeneration via nanoparticle-delivered miRNA
BioCentury | Apr 27, 2022
Deals
April 26 Quick Takes: CD24 will be new focus of Forty Seven founders as Stanford spinout Pheast debuts
Plus Nkarta follows breakthrough data with $200M raise, and updates from Epitopea, Forcefield and
BioCentury | Feb 2, 2022
Management Tracks
Roche’s William Pao joins Pfizer as CDO
Plus Clevers succeeds Pao at Roche, new CEO, CFO and other changes at Sosei and updates from Biomea, BeiGene, Cortexyme and more
BioCentury | Dec 2, 2021
Emerging Company Profile
AviadoBio: ‘Precision microdosing’ of gene therapies to the brain
Led by Zolgensma veteran Deschamps, start-up hopes to bring an FTD program to the clinic next year
BioCentury | Sep 23, 2021
Management Tracks
Vandebroek named CFO at Hyloris
Plus: Brooklyn ImmunoTherapeutics, Frazier, Renovacor, Rewind and more
BioCentury | Jun 23, 2021
Product Development
Treg start-ups — who, what and how much: Data Byte
Lining up Treg-focused newcos by their technologies, fundraising, and founders
Items per page:
1 - 10 of 132